Introduction: Atrial fibrillation and associated comorbidities pose a risk factor for mortality, morbidity and development of complications in patients admitted for COVID-19.
Objectives: To describe the clinical, epidemiological, radiological and analytical characteristics of patients with AF admitted for COVID-19 in Spain. Secondarily, we aim to identify those variables associated with mortality and poor prognosis of COVID-19 in patients with AF.
Methods: Retrospective, observational, multicenter, nationwide, retrospective study of patients hospitalized for COVID-19 from March 1 to October 1, 2020. Data were obtained from the SEMI-COVID-19 Registry of the Spanish Society of Internal Medicine (SEMI) in which 150 Spanish hospitals participate.
Results: Between March 1 and October 1, 2020, data from a total of 16,461 patients were entered into the SEMI-COVID-19 registry. 1,816 (11%) had a history of AF and the number of deaths among AF patients amounted to 738 (41%). Regarding clinical characteristics, deceased patients were admitted with a higher heart rate (88.38 vs 84.95; p > 0.01), with a higher percentage of respiratory failure (67.2% vs 20.1%; p < 0.01) and high tachypnea (58% vs 30%; p < 0.01). The comorbidities that presented statistically significant differences in the deceased group were: age, hypertension and diabetes with target organ involvement. There was also a higher prevalence of a history of cardiovascular disease in the deceased. On multivariate analysis, DOACs treatment had a protective role for mortality (OR:0,597) IC (0,402-0,888 ; p = 0.011).
Conclusions: Previous treatment with DOACs and DOACs treatment during admission seem to have a protective role in patients with AF, although this fact should be verified in prospective studies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579895 | PMC |
| http://dx.doi.org/10.1016/j.medcle.2022.01.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?
Rev Clin Esp (Barc)
November 2024
Department of Internal Medicine, Infanta Cristina University Hospital, Parla, Madrid, Spain.
Background: The study aimed to describe patient characteristics and outcomes by PaO2/FiO2 (PAFI) and degree of inflammation.
Methods: Retrospective cohort study with data on patients collected from March 1st, 2020 to March 1st, 2023, from the Spanish SEMI-COVID-19 Registry. Non-nosocomial patients with data on PAFI (<100 vs.
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry.
Sci Rep
October 2023
Internal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain.
Article Synopsis
- The study analyzed COVID-19 hospital admissions from 2020 in Spain, focusing on older patients during two pandemic waves, to evaluate mortality differences.
- Results showed a mortality rate of 20.4% during the first wave and 17.2% during the second wave, particularly among patients aged 70 and older, who had a significant mortality reduction of 7.6%.
- The lower mortality in the second wave may be due to improved healthcare standards, greater clinical experience, or less strain on the healthcare system, independent of patient or disease severity.
Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 Registry.
J Clin Med
July 2023
Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), 29016 Málaga, Spain.
Article Synopsis
- - The study investigates the relationship between COVID-19 and heart failure (HF), focusing on identifying risk factors for HF among hospitalized COVID-19 patients in Spain.
- - A total of 16,474 patients were analyzed, with 5.8% developing HF; significant risk factors included older age, atrial fibrillation, obesity, and peripheral vascular disease.
- - Patients who developed HF had notably higher mortality rates, increased need for intubation, and higher ICU admission rates compared to those who did not develop HF.
The impact of frailty on intra-hospital survival in older patients with COVID-19 infection: the importance of early identification. SEMI-COVID National Registry.
Rev Clin Esp (Barc)
October 2023
Internal Medicine Department, Regional University Hospital of Málaga, Instituto de Investigación Biomedica de Málaga (IBIMA- Plataforma BIONAND), University of Málaga (UMA), Málaga, Spain; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Background: Emerging evidence suggests that frailty may be a significant predictor of poor outcomes in older individuals hospitalized due to COVID-19. This study aims to determine the prognostic value of frailty on intrahospital patient survival.
Methods: This observational, multicenter, nationwide study included patients aged 70 years and older who were hospitalized due to COVID-19 in Spain between March 1 and December 31, 2020.
Improving prediction of COVID-19 mortality using machine learning in the Spanish SEMI-COVID-19 registry.
Intern Emerg Med
September 2023
Pediatrics Department, Clinical Research Unit, Hospital Universitario Vithas Madrid La Milagrosa, Fundación Vithas, Madrid, Spain.
Article Synopsis
- Researchers developed a machine learning model using Gradient Boosting Decision Trees (GBDT) to predict mortality in COVID-19 hospitalized patients, utilizing data from the Spanish SEMI-COVID-19 registry which included over 24,000 cases.
- The model employed advanced classifiers like CatBoost and BorutaShap to identify key indicators and risk levels for mortality, achieving a notable AUC performance of 84.76 in a test group likely containing vaccinated individuals.
- The study highlights the model's high predictive capacity despite needing a significant number of predictors, indicating its potential utility in clinical settings for managing COVID-19 patient care.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!